ARK Investment Management - JUNO THERAPEUTICS INC ownership

JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 166 filers reported holding JUNO THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.25 and the average weighting 1.0%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of JUNO THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$31,197,000
+108.6%
682,495
+36.4%
2.48%
-14.7%
Q2 2017$14,954,000
+171.4%
500,296
+101.5%
2.91%
+83.4%
Q1 2017$5,509,000
+105.9%
248,267
+74.9%
1.59%
+63.2%
Q4 2016$2,676,000141,9760.97%
Other shareholders
JUNO THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Biomark Capital Management Co. LLC 2,168,601$40,878,00084.62%
Crestline Management, LP 17,348,799$327,025,00081.61%
Omega Fund Management, LLC 1,229,512$23,176,00018.81%
SIB LLC 100,000$1,885,0001.52%
BB BIOTECH AG 1,870,000$35,250,0001.31%
Clearline Capital LP 116,200$2,190,0000.99%
ARK Investment Management 141,976$2,676,0000.97%
Clarius Group, LLC 117,896$2,222,0000.94%
SCOPIA CAPITAL MANAGEMENT LP 1,778,724$33,529,0000.64%
Baillie Gifford 11,061,955$208,518,0000.34%
View complete list of JUNO THERAPEUTICS INC shareholders